Flixonase Safety in Patients With Allergic Rhinitis (AR)
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This is an inception cohort study that analyses data from an administrative medical records
database. The two inception cohorts are: 1) patients initiated on intranasal FP and 2)
patients initiated on another INS (not FP). The candidates for the inception cohorts did not
use any intranasal steroid in the year prior to initiation.